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Atypical protein kinasePAR-6 is a conserved protein important for establishment and maintenance of cell polarity in a variety of
metazoans. PAR-6 proteins function together with PAR-3, aPKC and CDC-42. Mechanistic details of their
interactions, however, are not fully understood. We studied the biochemical interactions between C. elegans
PAR-6 and its binding partners and tested the requirements of these interactions in living worms. We show
that PB1 domain-mediated binding of PAR-6 to PKC-3 is necessary for polarity establishment and PAR-6
cortical localization in C. elegans embryos. We also show that binding of PAR-6 and PAR-3 is mediated in vitro
by a novel type of PDZ–PDZ interaction; the βC strand of PAR-6 PDZ binds the βD strand of PAR-3 PDZ1.
However, this interaction is dispensable in vivo for PAR-6 function throughout the life of C. elegans. Mutations
that speciﬁcally abolish conventional ligand binding to the PAR-6 PDZ domain also failed to affect PAR-6
function in vivo. We conclude that PAR-6 binding to PKC-3, but not to PAR-3 nor to a conventional PDZ
ligand, is required for PAR-6 cortical localization and function in C. elegans.The University of Texas M. D.
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Proteins encoded by the anterior par (partitioning defective) genes,
par-3, par-6 and atypical protein kinase C (pkc-3), are required in
C. elegans for establishing embryonic polarity, for apicobasal polari-
zation of non-epithelial early embryonic blastomeres and for proper
function of polarized epithelial cells (Aono et al., 2004; Nance et al.,
2003; Totong et al., 2007). PAR-6, PAR-3 and PKC-3 function toge-
ther in early embryonic polarity; they have indistinguishable loss-of-
function phenotypes, co-localize to the anterior cortex of the one-cell
embryo, and are co-dependent for this distribution (Etemad-Mogha-
dam et al., 1995; Hung and Kemphues, 1999; Tabuse et al., 1998;
Watts et al., 1996).
Proteins homologous to the anterior PAR proteins are conserved
amongmetazoans, and play similar roles in a variety of polarized cells
(Goldstein and Macara, 2007). For example, in Drosophila, Bazooka
(PAR-3), Par-6 and atypical protein kinase C (aPKC) are essential forestablishing oocyte polarity and maintaining oocyte cell fate (Cox
et al., 2001; Huynh et al., 2001). During Drosophila embryogenesis,
they are also important for apical–basal polarity of embryonic epi-
thelial cells and asymmetric cell division of neuroblasts (Kuchinke
et al., 1998; Muller and Wieschaus, 1996; Petronczki and Knoblich,
2001; Wodarz et al., 2000). In mammalian epithelial cells, Par6, Par3/
ASIP and aPKC play important roles in tight junction (TJ) formation
and apical–basal polarity establishment (Shin et al., 2006; Suzuki and
Ohno, 2006). PAR-6, PAR-3 and aPKC show extensive co-localization
and are interdependent for their asymmetric distribution not only in
C. elegans embryos but also in Drosophila epithelial cells and neuro-
blasts and in mammalian cells (Izumi et al., 1998; Lin et al., 2000;
Petronczki and Knoblich, 2001; Suzuki et al., 2001).
PAR-6 and its homologues play key roles by serving as scaffolds
that organize several other proteins (Par3, aPKC, Cdc42, Pals1/Stardust,
Crumbs/CRB3, Lgl) or regulate their functions or both. Drosophila and
mammalian homologues of PAR-6 and PKC-3(aPKC) bind directly,
forming PB1 domain heterodimers (Hirano et al., 2005; Lin et al., 2000;
Noda et al., 2003; Suzuki et al., 2001; Wilson et al., 2003; Yamanaka
et al., 2001) and in Drosophila neuroblasts this interaction is regulated
in a cell-cycle dependent manner (Wirtz-Peitz et al., 2008). The PDZ
domain ofmammalian andDrosophila Par-6 interactswith Par-3 PDZ1
(Joberty et al., 2000; Lin et al., 2000; Peterson et al., 2004). The well-
studied polarity regulator CDC-42 also binds directly to PAR-6 and is
required for PAR-6 function in C. elegans (Aceto et al., 2006; Gotta et al.,
2001; Kay and Hunter, 2001; Schonegg and Hyman, 2006) and other
animals (Etienne-Manneville and Hall, 2001; Hutterer et al., 2004;
Joberty et al., 2000; Johansson et al., 2000; Lin et al., 2000; Qiu et al.,
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to bind Cdc42 (Garrard et al., 2003; Joberty et al., 2000; Johansson
et al., 2000; Lin et al., 2000; Qiu et al., 2000). The Par-6 PDZ domain
can also bind ligands through its hydrophobic binding pocket. The
transmembrane ligand Crumbs/Crb3 binds to the Par-6 PDZ hydro-
phobic pocket through the Crumbs C-terminus in a Cdc42-dependent
fashion (Kempkens et al., 2006; Lemmers et al., 2004; Peterson et al.,
2004) whereas the Pals1/Stardust protein binds the Par-6 PDZ pocket
through an internal portion of the protein in a Cdc42-independent
fashion (Penkert et al., 2004; Peterson et al., 2004; Wang et al., 2004);
although see (Hurd et al., 2003) for evidence for dependence on Cdc42.
Lgl/Mlgl is another binding partner whose precise mechanism of
interaction is unclear but could also involve binding to the PDZ domain
of PAR-6 (Betschinger et al., 2003; Plant et al., 2003).
In C. elegans, the localization of PAR-6 is dependent upon PAR-3,
PKC-3 and CDC-42. In par-3 mutants and pkc-3(RNAi) embryos,
PAR-6 is absent from the cell cortex of early blastomeres (Hung and
Kemphues, 1999; Tabuse et al., 1998; Watts et al., 1996). In cdc-42
(RNAi) embryos and in embryos of par-6 mutants that block inter-
action with CDC-42, PAR-6 appears punctate or is undetectable at the
cell cortex (Aceto et al., 2006; Gotta et al., 2001; Kay andHunter, 2001;
Schonegg and Hyman, 2006). Genetic analysis and co-localization
results indicate that there are at least two modes by which PAR-6
can localize at the cortex, one that is CDC-42 dependent and one
that is independent of CDC-42 (Beers and Kemphues, 2006; Hung and
Kemphues, 1999); although see (Schonegg and Hyman, 2006) for
evidence suggesting complete dependence on CDC-42.
Although binding partners of mammalian and Drosophila Par6
have been identiﬁed, much remains unknown about the mechanisms
through which Par6 interacts with these partners and the conse-
quences of these interactions in vivo. Furthermore, little has been
reported about these interactions in C. elegans. To understand better
how these interactions relate to the localization and function of
PAR-6, we examined the biochemical interactions of C. elegans PAR-6
with PAR-3, PKC-3 and a heterologous PDZ domain ligand, Pals1, and
investigated the function of these interactions in vivo with mutated
par-6 transgenes that speciﬁcally block these interactions in vitro.
Here we report that, consistent with results from mammals and
ﬂies, C. elegans PAR-6 and PKC-3 associate through their PB1 domains;
PAR-6 PDZ can bind to PAR-3 PDZ1; and the three proteins can exist as
a protein complex in vivo. We also found that the PDZ–PDZ interaction
between PAR-3 and PAR-6 occurs via a novel type of binding. By
studying transgenic lines expressing mutated GFP-tagged PAR-6, we
learned that the interaction between PAR-6 and PKC-3 is necessary
for polarity establishment and PAR-6 cortical localization in the early
embryo. Surprisingly, however, disrupting either the PAR-6 PDZ inter-
action with PAR-3 PDZ1 or disrupting the ability of the PAR-6 PDZ
to bind a PALS-1-like ligand had little or no effect on PAR-6 function
in vivo.
Materials and methods
Yeast two-hybrid screen and assays
Full-length par-6 cDNA was cloned into the pAS1-CYH2 vector
(Bai and Elledge, 1996). Yeast transformants carrying pASPAR-6
were tested for PAR-6 expression by Western blot. A mixed-staged
C. elegans library constructed in the pACT2 vector (a gift from Dr. Bob
Barsted) was transformed into pASPAR-6 yeast according to the pro-
tocol of (Bai and Elledge, 1996). Approximately 600,000 yeast trans-
formants were plated on selective medium [SC-Trp, Leu, His+50 mM
3-amino 1,2,4 triazole (3-AT)]. The His+clones were plated on selec-
tive medium and scored for β-galactosidase (β-gal) activity. The
positive clones were identiﬁed by their dependence on PAR-6 to
activate HIS3 and β-gal expression and were sequenced. To assay
speciﬁc protein/protein interactions, full-length and fragments ofpar-6, pkc-3 and par-3were cloned into pAS1-CYH2 and pACTII vectors
(Bai and Elledge, 1996;Durfee et al., 1993;Harper et al., 1993) for yeast
two-hybrid assays.
Binding assays with GST fusion proteins
For in vivo pull-down experiments, embryos were harvested from
gravid worms (Etemad-Moghadam et al., 1995). Embryos were resus-
pended in C buffer (40 mM HEPES pH7.4, 150 mM NaCl, 10% glycerol,
1 mM EDTA, protease inhibitor cocktail from Roche) and proteins
extracted by sonication. The embryo protein homogenate was cen-
trifuged at 100,000×g for 45 min. GST-PAR-3245–932 or GSTwas bound
to glutathione beads. Embryo extracts were mixed with 20 μl of
GST-PAR-3245–932 or GST-bound beads, incubated at 4 °C for 2h, and
subsequently washed six times with C buffer. Bound proteins were
extracted using SDS sample buffer, and then subjected to SDS-PAGE
and Western blotting.
For in vitro binding assays, full-length par-6 cDNA and fragments of
the gene were cloned into the pQE32 (Qiagen) or pGEX-4T-1 vectors
(Pharmacia Biotech). PKC-3 fragments were cloned into the pGEX-5X-
1 vector (Pharmacia Biotech). PAR-3 fragments were cloned into the
pMAL-c2 vector (NEB). Recombinant proteins were produced in E. coli
BL21. 6His or MBP fusion protein-containing bacterial pellets were
sonicated in binding buffer (1× PBS, 0.1% Triton X-100). After ultra-
centrifugation, the supernatant was incubated with GST fusion pro-
teins immobilized on Glutathione beads for 2 h at 4 °C and washed
with binding buffer six times. The beads were boiled with 2× SDS
sample buffer. Eluted proteins were separated by SDS-PAGE and
detected by Gelcode Blue staining (Pierce) or transferred to nitro-
cellulose membranes and detected by immunoblotting (Burnette,
1981) using rabbit antibodies to PAR-6 (1:1000) (Hung andKemphues,
1999), rabbit antibodies to MBP tag (1:10,000) (NEB), HRP-conjugated
goat anti-rabbit antibodies (1:10,000) (Jackson ImmunoResearch) and
chemiluminescent reagents (Amersham Biosciences).
To test the interaction between PAR-6 and Pals1 or CDC-42, in vitro
binding assayswere carried out according to themethods of (Peterson
et al., 2004).
Co-immunoprecipitation
Embryo protein extracts prepared as described above were pre-
cleared by treatment with Protein A beads lacking antibody and then
subjected to immunoprecipitation using beads bound with afﬁnity-
puriﬁed anti-PAR-6, anti-PAR-3, or anti-ZYG-9 (control) antibodies
(Etemad-Moghadam et al., 1995; Hung and Kemphues, 1999; Mat-
thews et al., 1998). After immunoprecipitation, Protein A beads were
washed (40 mM HEPES pH7.4, 150 mM NaCl, 10% glycerol, 1 mM
EDTA, 1% Triton X-100), and eluted with 0.1 M glycine, pH 2.8. The
elutions were precipitated with Trichloroacetic acid (TCA) at a ﬁnal
concentration of 20%. The precipitates were washed once with ice-
cold acetone, dried, boiled in SDS sample buffer and subjected to SDS-
PAGE and Western blotting.
Production of transgenic lines
For analysis of the PAR-6–PKC-3 interaction in the early embryo,
GFP::PAR-6 and GFP::PAR-6Δ15–28 lines were generated according to
the complex arraymethod (Kelly et al., 1997; Mello et al., 1991). par-6
and par-6Δ15–28 cDNAs cloned into pJAM (Aceto et al., 2006) were
linearized and co-injected with PvuII-cut genomic DNA into the
gonads of young adult KK818 par-6(zu222) unc-101(m1)/hIn1[unc-54
(h1040)]I worms. Lines producing rolling progenywere tested for GFP
expression and ability to rescue par-6(zu222) homozygous segre-
gants in the F2 and F3 generations. Most lines generated using this
transgenesis method underwent germline silencing within a few
generations.
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requirement for PAR-6 function in vivo, we generated transgenic lines
carrying WT or mutated gfp::par-6 cDNA transgenes driven by the
pie-1 promoter in the vector pAJS100 (pJunc) (Beers and Kemphues,
2006) using biolistic bombardment (Praitis et al., 2001) of unc-119
(ed3); par-6(zu222)unc-101(m1)/hIn1[unc-54(h1040)]. To test the
maternal effect of a particular mutation on embryonic viability, eggs
laid by par-6(zu222) unc-101 homozygotes were monitored for hatch
rate.
To test the effect of PAR-6 mutants on the zygotic requirement for
PAR-6, we used biolistic bombardment to generate transgenic lines
expressing GFP-tagged wild-type or mutated genomic par-6 under
the control of its own promoter. Mutations were generated by fusion
PCR using pJN284 as template (Nance et al., 2003). We bombarded
par-6::gfp transgenes directly into KK1002, par-6(tm1425)/hIn1[unc-
54(h1040)]; unc-119(ed3). In a typical bombardment, of about 30 non
Unc-119 lines recovered, about 10 behaved as homozygous viable
chromosomal integrations and three to ﬁve expressed GFP. Progeny
from par-6(tm1425)/hIn1(unc-54) heterozygotes segregate three
genotypes: par-6(tm1425)/par-6(tm1425), which arrest as L2 larvae,
par-6(tm1425)/hIn1(unc-54), which are phenotypically wild-type,
and hIn1(unc-54)/hIn1(unc-54), which are paralyzed Unc. Rescue was
scored as the ability to recover individual wild-type-looking fertile
worms that failed to segregate Unc-54 progeny. To verify the pre-
sumed genotype of the rescued lines, we collected fertile wild-type
appearing adults from one line per each transgene, and genotyped
them by single-worm PCR using primer sets that could detect the
tm1425 deletion, the rescuing par-6::gfp transgene, and the par-6(+)
gene in the balancer.
Microscopy and immunoﬂuorescence
To visualize GFP signals in living embryos, embryos were dissected
out of gravid adult worms in distilled H2O, mounted on agar pads and
imaged at approximately 23 °C. Openlab software was used to make
time-lapse movies on a Leica DM RA2 microscope equipped with aFig. 1. PAR-3, PAR-6 and PKC-3 form complexes in embryo extracts. A) Western blot showing
from embryo extracts. B) Western blot showing co-puriﬁcation of PKC-3 and PAR-6 from em
used for the control IP in panels B, C and D. C) Western blot showing co-puriﬁcation of PA
showing results of IP with anti-PAR-6 antibodies. Note the absence of detectable PAR-3 pro63× Leica HCX PL APO oil immersion lens and a Hamamatsu ORCA-ER
digital camera.
For confocal analysis, embryos were ﬁxed in methanol following
previously published procedures (Guo and Kemphues, 1995). The
following primary antibodies and dilutions were used: anti-PAR-3
mouse monoclonal (Nance et al., 2003) at 1:20; anti-PAR-6 rabbit
polyclonal (Hung and Kemphues, 1999) at 1:20. Incubation times and
temperatures were as described by Nance et al. (2003). Primary
antibodies were detected by Cyc3 labeled goat anti-mouse (Jackson
ImmunoResearch Laboratories, Inc.) at 1:200 and Alexa Fluor 488
labeled goat anti-Rabbit (Invitrogen) at 1:200. Confocal images were
collected on a Leica TCS SP2 system with a Leica DMRE-7 microscope
and an HCX PL APO 63× oil immersion lens. Images were processed
using the Leica Confocal SP2 software program and Adobe PhotoShop.
To quantify degree of co-localization of PAR-3 and PAR-6, three to
four embryos were analyzed for each genotype. Six cortical sec-
tions 0.25 μm apart were projected to obtain each image for analysis.
For each embryo, two independent regions were analyzed. For each
image, background, as deﬁned by the cytoplasmic signal at the pos-
terior cortex, was removed; remaining cortical puncta were analyzed
for overlap.
Results
PAR-6, PAR-3 and PKC-3 can form a protein complex in embryo extracts
Par-3, Par-6 and atypical protein kinase C (aPKC) form complexes
in mammalian cells and Drosophila embryos. To determine whether
this is also true in C. elegans embryos, we tested whether the proteins
could be co-puriﬁed from embryo extracts. Extracts were prepared
from embryos collected from young gravid adults; such embryos vary
in developmental age but are enriched for stages prior to gastrulation.
We ﬁrst examinedwhether endogenous PKC-3 and PAR-6 proteins
in embryo extracts can bind to GST-PAR-3245–932, which contains all
three PDZ domains and the putative PKC-3 binding/phosphorylation
domain (Etemad-Moghadam et al., 1995). Indeed, as shown in Fig. 1A,co-puriﬁcation of PKC-3 (upper band) and PAR-6 (lower band) with GST-PAR-3245–932
bryo extracts after immunoprecipitation (IP) with anti-PAR-3. Anti-ZYG-9 antibody was
R-3 and PKC-3 after IP with anti-PAR-6. D) Gelcode Blue-stained poly-acrylamide gel
tein (asterisk). ZYG-9, the control IP, migrates at a position similar to PAR-3.
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with GST alone, that PAR-6 and PKC-3 can associate with PAR-3 in
embryo extracts.
To further explore the potential interaction between PAR-3, PAR-6
and PKC-3 in vivo, we examined whether PAR-6 and PKC-3 could
be co-immunoprecipitated from embryo extracts with PAR-3 (see
Materials and methods). As indicated in Fig. 1B, PAR-6 and PKC-3 co-
precipitated with PAR-3 using anti-PAR-3 antibody but not control
anti-ZYG-9 antibody, demonstrating that PAR-3 can associate with
PAR-6 and PKC-3 in vivo.
In a reciprocal co-immunoprecipitation experiment using anti-
PAR-6 antibodies, PAR-3 and PKC-3 were also detected in the IP com-
plex by immunoblotting (Fig. 1C). However, by protein staining,
we could detect both PAR-6 and PKC-3 but could not detect PAR-3
(Fig. 1D). This result suggests that there is a strong interactionbetween
PAR-6 and PKC-3 in vivo; however, the interaction of these proteins
with PAR-3 may be weaker or more dynamic. Alternatively, only a
small fraction of PAR-3 may strongly associate with PAR-6 in vivo.
PAR-6 and PKC-3 bind to each other through their PB1 domains
To identify binding partners of PAR-6, we undertook a two-hybrid
screen of a C. elegans mixed-stage cDNA library using full-length
PAR-6 as bait. We recovered six positive clones out of 6×105 trans-
formants, ﬁve of which encode PKC-3.
To determine the precise nature of the interaction between PAR-6
and PKC-3 we divided the PKC-3 coding sequences in two: an N-
terminal portion encoding the regulatory domain (amino acids 1–257)
and the reciprocal C-terminal portion encoding the catalytic domain
(amino acids 258–597). Like other PKCs, the N-terminal portion of
PKC-3 contains a pseudosubstrate sequence that is proposed to act as a
regulator of its kinase activity (Wu et al., 1998). In yeast two-hybrid
assays, we found that full-length PAR-6 was able to interact with PKC-
31–257 but not PKC-3258–597 (Fig. 2A) and by both yeast two-hybrid
(Fig. 2A) and by direct binding (Fig. 2B) that this interaction was
mediated by the N-terminal half of PAR-6 (amino acids 1–138).
Analysis of mammalian Par-6 and aPKC revealed that both proteins
contain a conserved PB1 domain at their N-termini and that these
domains bind to each other (Hirano et al., 2005; Noda et al., 2003;
Wilson et al., 2003). We conﬁrmed this interaction for the C. elegans
proteins using yeast two-hybrid and in vitro binding assays; a PAR-6
fragment containing the PB1 domain (amino acids: 1–126) interacts
with a fragment of PKC-3 containing its PB1 domain (amino acids:18–
95) whereas fragments of PAR-6 or PKC-3 deleted for all or part of
either of the PB1 domains did not interact (Fig. 3A and data not
shown). Thus, similar to their mammalian homologues, PAR-6 and
PKC-3 appear to interact with each other in vitro through their PB1
domains.Fig. 2. PKC-3 and PAR-6 interact via their N-terminal domains. A) Interaction between
PAR-6 NT (amino acids 1–138) and PKC-3 NT (amino acids 1–257) by yeast two-hybrid
assay (A) and by direct binding of bacterial fusion proteins (B). Panel B shows a western
blot probed with anti-PAR-6 antibody.Interaction of PAR-6 with PKC-3 is necessary for polarity establishment
and PAR-6 cortical localization
To determine the importance of the interaction between PKC-3
and PAR-6 in living animals, we constructed a mutant form of PAR-6
unable to bind to PKC-3. We found that deleting the highly conserved
amino acids 15–28 within the PAR-6PB1 domain disrupted the inter-
action of PAR-6 with PKC-3 in yeast two-hybrid assays without pre-
venting its interaction with PAR-3 or constitutively active CDC-42
(Fig. 3A). In pkc-3(RNAi) embryos, PAR-6 is no longer localized to
the cortex (Tabuse et al., 1998), raising the possibility that binding to
PKC-3 mediates PAR-6 cortical localization. To test this possibility, we
used DNA microinjection to generate lines of worms that expressed
the gfp::par-6Δ15–28 transgene under the control of the pie-1 promoter
and determined the distribution of the mutant protein and its ability
to rescue viability of embryos from par-6(zu222)mothers, which lack
maternally-provided PAR-6 (see Materials and methods). Control
par-6(zu222)mothers expressing awild-type gfp::par-6 transgene pro-
duced 672/2053 viable embryos, whereas none of seven independent
lines expressing the gfp::par-6Δ15–28 transgene rescued the lethality or
polarity defects of embryos from homozygous par-6(zu222) mothers
(0/5225 embryos hatched).
PAR-6 normally accumulates at the anterior cortex of the C. elegans
zygote. In both par-6(+)/par-6(zu222) and par-6(zu222) embryos
we observed cytoplasmic accumulation of GFP::PAR-6Δ15–28, but no
cortical localization (Fig. 3B). This result indicates that PAR-6 inter-
action with PKC-3 is important for polarity establishment and PAR-6
cortical localization. However, because the pie-1 promoter only ex-
presses maternally and the zu222 mutation is maternal-speciﬁc, this
experiment does not address a possible role for PAR-6–PKC-3 inter-
action in late embryogenesis or larval development.
To test whether interaction of PAR-6 with PKC-3 is important
during later development of C. elegans, we tested whether expression
of PAR-6Δ15–28::GFP from the par-6 endogenous promoter could re-
scue the putative par-6 null allele, tm1425 (Totong et al., 2007). The
par-6(tm1425) allele is a 853 bp deletion that spans the ﬁrst exon to
the second intron of T26E3.3a, which is the longer of the two isoforms
of PAR-6. tm1425 homozygotes can proceed through embryogene-
sis due to the maternal load of PAR-6, but arrest as young larvae.
Out of 29 lines transformed with par-6WT::gfp, we recovered nine
integrated lines, three of which expressed PAR-6WT::GFP driven by
the endogenous promoter. The par-6WT::gfp transgene fully rescued
homozygous tm1425 worms and exhibited tissue and subcellular
distributions consistent with previous analyses (Totong et al., 2007).
For par-6Δ15–28::gfpwe recovered 34 lines in two independent biolistic
transformation experiments; only two lines integrated the transgene
into the genome and neither expressed GFP. We examined ten non-
integrated lines, and recovered seven lines that express some GFP.
When we examined expression in these lines, we noted that GFP
accumulated in the cytoplasm of various tissues including hypoder-
mis, vulva, and cells near the pharynx. Surprisingly, very few worms
showed accumulation of PAR-6Δ15–28::GFP in either pharynx or intes-
tine, where PAR-6WT::GFP is readily detected. In those few worms,
expression was mosaic with only one or two of the intestinal cells or
the pharyngeal cells expressing GFP. In those cells the mutant protein
accumulated in the cytoplasm, but not the apical cortex (Fig. 4), con-
sistent with our results from expression in the early embryo. We
tested two lines with rare mosaic expression for rescue of the larval
lethality in par-6(tm1425) and saw no rescue; however, this could be
due to themosaic expressionof the par-6Δ15–28::gfp transgene. Because
we did not recover any integrated lines with PAR-6Δ15–28::GFP ex-
pression and lines with extrachromosomal arrays show only rare and
mosaic GFP expression in the tissues where PAR-6 is normally ex-
pressed, it is possible that expressing PAR-6Δ15–28::GFP in late stage
embryos or larvae is toxic and we were only able to recover lines with
weak ormosaic expression. Alternatively, coding sequences deleted in
creating the transgene may be essential for proper expression.
Fig. 3. The PB1 domain of PAR-6 is essential for binding to PKC in vitro and for function in vivo. A) Diagram showing deleted region of PAR-6 (amino acids 15–28) within the
PB1 domain. B) Yeast two-hybrid assays showing interaction of wild-type PAR-6 or PAR-6Δ15–28 with PKC-3, PAR-3 or constitutively active CDC-42. PAR-6Δ15–28 does not interact
with PKC-3. C) Distribution in living embryos of GFP::PAR-6 (top) and GFP::PAR-6Δ15–28 (bottom). The mutant protein fails to localize to the cell cortex. The transient localization of
GFP::PAR-6Δ15–28 to the nucleoplasm just after nuclear envelop breakdown, as seen in the second panel, also occurs with GFP::PAR-6.
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Previous work in mammals and ﬂies revealed a weak interaction
between PDZ1 of Par3 and the PDZ domain of Par6 (Joberty et al.,
2000; Lin et al., 2000; Peterson et al., 2004). C. elegans PAR-6 and
PAR-3 have protein structures similar to their mammalian and
Drosophila homologues. We ﬁrst conﬁrmed that C. elegans PAR-3 and
PAR-6 could interact in yeast two-hybrid and in vitro binding assays.
Full-length PAR-6 could interact in both assays with a fragment of
PAR-3 containing its three PDZ domains (amino acids 383–754) and
with a fragment containing PDZ1 (amino acids 383–516), but not with
a PAR-3N-terminal fragment (amino acids 1–383), fragments contain-
ing PDZ2 (amino acids 501–651 for yeast two-hybrid and 517–651 for
in vitro assays) or PDZ3 (amino acids 627–724 for yeast two-hybrid
and 652–775 for in vitro assays) or a C-terminal fragment including
PDZ3 and the remainder of the carboxy-terminus (amino acids 637–
1397) (Fig. 5A). As evidence for speciﬁcity of this interaction,we found
that neither PAR-3 nor PAR-6 interact with LIN-7, another C. elegansFig. 4. Distribution of GFP::PAR-6 wild-type (WT) and GFP::PAR-6 mutant fusion proteins,
intestine. Note the mosaic expression of GFP::PAR-6Δ15–28 and its failure to localize apicallyPDZ containing protein (Kaech et al., 1998) (Fig. 5A). We further
conﬁrmed an interaction between PAR-6 PDZ (amino acids 139–252)
and PAR-3 PDZ1 (amino acids 383–516) in both yeast two-hybrid and
in vitro binding assays (Fig. 5B). This appears to be a relatively weak
interaction. Under the same in vitro binding conditions both MBP::
PAR-3 PDZ1 and MBP::mPals1 peptide (see below) can be puriﬁed
from bacterial cell extracts using GST::PAR-6 PDZ. Although both can
be detected by western blot, only MBP::mPals1 peptide is detectable
by protein staining (Fig. 6A, ﬁrst lane).
PAR-6/PAR-3 interaction is not essential for PAR-6 function
PDZ domains are 80–100 amino acid regions that form a globular
domain composed of ﬁve or six β strands (βA–F) and two α helices
arranged into what has been described as an ‘up-and-down β barrel’
(Doyle et al., 1996; Hillier et al., 1999; Morais Cabral et al., 1996). The
βB strand, the αB helix and the loop connecting the βA and βB strand
generate a hydrophobic binding pocket, through which PDZ domainsas indicated, in adult pharynx and intestine, larval vulvae, and embryonic pharynx and
.
Fig. 5. PAR-6 PDZ and PAR-3 PDZ1 mediate binding between the two proteins. A) PAR-6 binds to PDZ1 of PAR-3. Two-hybrid assays are on the left. The western blot on the right
shows detection of MBP-tagged PAR-3 fragments with anti-MBP antibody following binding to GST-PAR-6 on glutathione agarose beads. Coomassie Brilliant Blue staining of GST-
PAR-6 in the reaction is shown below the western blot. B) PAR-3 PDZ1 binds to PAR-6 PDZ. Two-hybrid assays are on the left. The western blot on the right shows detection of MBP-
PAR-3 PDZ1 with anti-MBP antibody following binding to GST-tagged PAR-6 fragments, which are shown below the western blot.
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et al., 1996; Penkert et al., 2004). Themost common PDZ-binding part-
ners are transmembrane proteins that insert their intracellular car-
boxyl terminus into the hydrophobic binding pocket of PDZ domains
(Doyle et al., 1996; Hung and Sheng, 2002). In a few cases, internal
protein segments can insert into the binding pocket. For example, the
nNOS PDZ domain interacts with the syntrophin PDZ domain through
a β ﬁnger which is a C-terminal extension of the nNOS PDZ (Hillier
et al., 1999). The PDZ domain of Par6 can also bind an internal seg-
ment of the protein Pals1 (Penkert et al., 2004), but Pals1 does not
have a β ﬁnger. To accommodate the internal peptide of Pals1, the
Par6 PDZ domain is deformed (Penkert et al., 2004).
We investigated themechanismbywhich PAR-6 PDZ (amino acids:
139–252) interacts with PAR-3 PDZ1 (amino acids: 383–516). To test
whether PAR-3 PDZ could be binding to the peptide-binding pocket
of PAR-6 PDZ,weﬁrst veriﬁed that C. elegans PAR-6 PDZ could bind to a
known ligand. Because there is no known ligand for C. elegans PAR-6,
we tested the ability of mammalian Pals1 (Hurd et al., 2003) to bind to
the C. elegans PAR-6 PDZ domain in a GST pull-down assay. As shown
in Fig. 6A, MBP::mPals1(amino acids 30–42) binds strongly enough
to the PAR-6 PDZ domain that we can detect co-puriﬁed protein
by staining. Mutations in the carboxylate binding loop of mPar6
PDZ disrupted the interaction between mPar6 and Pals1 (Hurd et al.,
2003). We mutated the corresponding residues (RPLG166–169AAAA)
of C. elegans PAR-6 PDZ and found that this quadruple mutation abol-
ished C. elegans PAR-6 interaction with mammalian Pals1 (Fig. 6A).
However, the mutation did not affect PAR-6 binding to PAR-3 in vitro
(Fig. 6B). Another mutation, M234W), altering the C. elegans PAR-6
PDZ domain deep within the hydrophobic binding pocket, weakens
PAR-6 PDZ interaction withmammalian Pals1, and, like the quadruple
mutant, does not affect PAR-6 to PAR-3 binding (data not shown).This suggests that in C. elegans, PAR-3 does not bind to the canonical
hydrophobic binding pocket of PAR-6 PDZ. We also created mutations
in the carboxylate binding loop of PAR-3 PDZ1 (KQLG395–398AAAA)
and found no effect on interaction with PAR-6 (Fig. 6B), suggesting
that C. elegans PAR-6 does not bind to the canonical hydrophobic
binding pocket of PAR-3 PDZ1.
To ﬁnd the minimal regions that mediate the interaction between
PAR-6 and PAR-3, we made a series of deletion constructs within
MBP::PAR-3 PDZ1 and GST::PAR-6 PDZ and tested their ability to
interact in in vitro in a GST pull-down assay. As summarized in
Supplemental Fig. S1, we found that the βC strand of PAR-6 PDZ is
necessary to interact with PAR-3 PDZ1 and the βD strand of PAR-3
PDZ1 is necessary to interact with PAR-6 PDZ (for example, Fig. 6C,
lane 2; Supplemental Fig. S1). We then tested the βC strand of PAR-6
PDZ and the βD strand of PAR-3 PDZ1 in the same assay and deter-
mined that these fragments were sufﬁcient to promote binding to the
other PDZ domain (Supplemental Fig. S1).
To determine how disrupting the interaction with PAR-3 affects
PAR-6 function in C. elegans in vivo, we ﬁrst identiﬁed mutations that
speciﬁcally disrupt this interaction in vitro. Because the LIN-7 PDZ
domain does not bind to PAR-3 PDZ1 (Fig. 5A), we mutated two
residues in the βC strand of PAR-6 PDZ to match the corresponding
residues in the βC strand of LIN-7 PDZ (F192Y, D198P;(Kaech et al.,
1998)). These mutations signiﬁcantly reduced the binding between
PAR-6 and PAR-3 (Fig. 6D; upper panel). PAR-6 PDZF192Y, D198P can still
interact with mammalian Pals1 (Fig. 6D; lower panel), suggesting
that the overall PDZ structure is not affected by these mutations.
Mutations of three residues in the βD strand of PAR-3 PDZ1 (C445R,
A448E, and D450N) to match the corresponding residues in the
βD strand of PAR-3 PDZ2 also signiﬁcantly weakened the interaction
between PAR-6 and PAR-3 (Fig. 6C; right lane).
Fig. 6. Binding of PAR-3 PDZ1 to PAR-6 PDZ is not likely to depend on binding through the hydrophobic pocket. A) Coomassie Brilliant Blue stained gel showing co-puriﬁcation of
MBP-Pals1 (aa 30–42) expressed in bacteria with wild-type bacterially expressed GST-PAR-6 PDZ domain but not with GST-PAR-6 PDZ domain containing a four amino acid
substitution in the hydrophobic pocket. B) Western blot showing co-puriﬁcation of MBP-PAR-3 PDZ1 with wild-type and mutant forms of GST-PAR-6 PDZ. The lower panel
shows Coomassie staining of GST-PAR-6 PDZ eluted from glutathione beads; the PAR-3 PDZ1 protein was not detectable by protein stain. C) GST pull-down assay for MBP fusions
of wild-type and mutant PAR-3 PDZ1. Middle panel is Coomassie stain, top and bottom are western blots with anti-MBP antibody. MBP-PAR-3 PDZ2 serves as negative control.
D) Co-puriﬁcation of GST-PAR-6 PDZ and GST-PAR-6 PDZF192Y D198P with MBP-PAR-3 PDZ1 and MBP-Pals1 peptide showing reduced binding to the mutated fusion protein as
seen with anti-MBP (upper panel) but no effect on binding to the MBP-Pals1 peptide as seen with Coomassie stain (lower panel).
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lacking maternally-provided PAR-6 to determine the in vivo effect
of these mutations. Expression of the GFP::PAR-6F192Y,D198P mutant
rescued the embryonic lethality of par-6(zu222) worms as well asFig. 7. Embryos expressing GFP::PAR-6 and GFP::PAR-6 with the indicated mutations in the P
and four-cell stages.control GFP::PAR-6WT (85% of 303 embryos hatched compared to
86% of 313 control embryos). Consistent with embryonic rescue, the
subcellular distribution of GFP::PAR-6 PDZF192Y, D198P matched that of
the endogenous PAR-6 protein (Fig. 7), with normal anterior corticalDZ domain. Embryos are shown at one-cell pseudocleavage, one-cell prophase, two-cell
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null allele, and has normal zygotic par-6 expression, we expected that
the rescued embryoswould grow to adulthood. However,we observed
that only 11% of the hatched embryos reached adulthood. This larval
lethality appeared to be due to a combined effect of dominant negative
effects of transgene expression and the subvital nature of the unc101
marker, since animals carrying the transgene and also heterozygous
for unc-101 par-6(zu222) exhibited 25% larval lethality and control
unc101 homozygotes showed 40% larval lethality. Assuming that this
mutant GFP::PAR-6 PDZF192Y, D198P severely compromises direct bind-
ing to PAR-3 in vivo, this result indicates that the direct interaction
between PAR-6 and PAR-3 PDZ1 is not essential for viability or proper
distribution in the C. elegans early embryo. Although this result does
not address whether there is an essential role for this interaction in
later stage embryos or during larval development, independent results
with structure/function analysis of PAR-3 ruled this out (B. Li andK. K.;
see discussion).
The observation that direct interaction between PAR-3 and
PAR-6 appears not to be required raised the question of whether
the PAR-6F192Y, D198P::GFP exhibited an altered co-localization with
PAR-3 in vivo. To test this possibility, we examined the distribu-
tion of PAR-3 and PAR-6F192Y, D198P::GFP in par-6(zu222) homozy-
gotes. In wild-type embryos, PAR-3 and PAR-6 co-localization is
dynamic such that only about 40% of the cortical puncta recognized
by the two proteins contain detectable levels of both proteins (Hung
and Kemphues, 1999). If the direct interaction between the two pro-
teins plays a signiﬁcant role in complex formation, we expected that
we might see fewer cortical puncta that contained both PAR-3 and
PAR-6F192Y, D198P::GFP relative to PAR-6::GFP. We found no signiﬁcant
difference between the extent of co-localization of the two proteins;
41±4% of the puncta contained both PAR-3 and PAR-6::GFP and
44±1% of the puncta contained both PAR-3 andPAR-6F192Y, D198P::GFP
(Fig. 8). As a control for possible effects of transgene expression, we
also examined untransformedwild-type embryos (N2) and noted that
although the overall level of PAR-6 protein appeared lower, the extent
of co-localization was similar; 35%±4.
Disrupting ligand binding to the PDZ domain does not affect PAR-6
cortical localization and function in C. elegans embryos
The PDZ domain of Par6 is highly conserved (Joberty et al., 2000;
Qiu et al., 2000), cooperates with the semi-CRIB domain to bind Cdc42
(Garrard et al., 2003; Joberty et al., 2000; Qiu et al., 2000) and can bindFig. 8. Confocal cortical images of one-cell embryos double labeled with anti-PAR-3 and an
homozygous for par-6(zu222). The three panels below each embryo show images of the box
green, anti-PAR-3 in red and the overlay of the two channels is the rightward panel. Two regi
GFP::PAR-6 and GFP::PAR-6F192Y D198P; four embryos were used for N2 (see Materials andto the C-terminus of Crumbs/CRB3 (Kempkens et al., 2006; Lemmers
et al., 2004) or to an internal segment of Pals1 (Penkert et al., 2004;
Wang et al., 2004). We wished to determine the in vivo consequences
of blocking the binding of PAR-6 PDZ to its presumed and unknown
C. elegans ligand(s). To control for disruption of the overall PDZdomain
structure, we tested our mutations in the context of a fragment of
PAR-6 that includes the semi-CRIB domain and the PDZ domain
(amino acids 126–252). Because binding to CDC-42Q61L requires pro-
per folding of the PDZ domain (Garrard et al., 2003), we sought
mutations that blocked binding to Pals1 but could still bind to CDC-
42Q61L. We tested twelve mutations shown in other studies to disrupt
PDZ–ligand interactions (Hurd et al., 2003; Peterson et al., 2004;Wang
et al., 2004) to identify three that blocked ligand binding to mPals1
in vitro without reducing binding to CDC-42 or PAR-3 PDZ1: P167G,
K161A and the double mutant R166A P167A (Supplemental Fig. S2).
P167G and K161A seemed to increase binding to CDC-42Q61L. Thenwe
generatedGFP::PAR-6 transgenic lines carrying thesemutations to test
their effect on PAR-6 distribution and function in vivo. Unexpectedly,
all threemutant constructs at least partially rescue thematernal-effect
embryonic lethality and polarity defects of par-6(zu222) homozy-
gotes [71% of embryo viability for GFP::PAR-6K161A, 59% of embryo
viability for GFP::PAR-6R166A,P167A and 76% of embryo viability for
GFP::PAR-6P167G]. TheGFP signal in the embryos of all these transgenic
lines is asymmetric at the cortex, similar to wild-type PAR-6 (Fig. 7).
Assuming that the mutations block the ability to bind PDZ ligands
in vivo, ligand binding to the PDZ domain is not essential for PAR-6
localization or function in the early embryo.
To test whether a functional hydrophobic binding pocket is essen-
tial for PAR-6 PDZ domain function during later development of
C. elegans, when zygotically expressed PAR-6 is required, and to verify
the surprising results with the maternally expressed protein, we gen-
erated transgenic lines that express wild-type or mutant PAR-6::GFP
driven from the par-6 promoter in a par-6(tm1425)/hIn1(unc-54)
background. We recovered integrated and expressing lines for PAR-
6WT::GFP (3 lines) PAR-6R166A, P167A::GFP (4 lines) and for PAR-6P167G::
GFP (5 lines). For two lines from each genotype, we determined the
pattern of GFP accumulation in homozygous par-6(tm1425)worms by
whole-mount ﬂorescence imaging and tested the ability of the lines to
rescue the lethality. In transgenic lines expressing PAR-6WT::GFP, GFP
accumulated as previously reported for this construct (Totong et al.,
2007), including on the apical surface of the pharynx and apical
junctions of intestine cells in late embryos from comma stage to about
2-fold stage. In larvae and adults, GFP accumulated on the apicalti-PAR-6 antibodies. Embryos expressing GFP::PAR-6 and GFP::PAR-6F192Y D198P were
ed region after processing to remove background ﬂuorescence; anti-PAR-6 is shown in
ons of each of three embryos were used for quantifying the degree of co-localization for
methods).
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Both mutant proteins showed a distribution indistinguishable from
wild-type. Consistent with this, all of these mutant transgenic lines
rescued tm1425homozygotes aswell aswild-typePAR-6::GFP. Indeed,
for both mutant transgenes, we were able to establish stable lines
homozygous for tm1425 and carrying the transgene as the only source
of full-length PAR-6 as veriﬁed by PCR genotyping.Discussion
C. elegans PAR-3, PAR-6, and PKC-3 co-localize at the anterior
cortex of one-cell zygotes, and mutations in the three genes share a
common maternal-effect lethal cell polarity phenotype (Cheng et al.,
1995; Etemad-Moghadam et al., 1995; Hung and Kemphues, 1999;
Kemphues et al., 1988; Tabuse et al., 1998; Watts et al., 1996). The
overall protein structures of the three and their involvement in
cell polarity are conserved (Goldstein and Macara, 2007; Suzuki and
Ohno, 2006). Studies of mammalian and fruit ﬂy homologues of
PAR-3, PAR-6, and PKC-3 reveal conserved biochemical interactions
among the proteins (Izumi et al., 1998; Joberty et al., 2000; Lin et al.,
2000; Nagai-Tamai et al., 2002; Petronczki and Knoblich, 2001; Qiu
et al., 2000; Suzuki et al., 2001; Wodarz et al., 2000; Yamanaka et al.,
2001). We previously showed that interaction of PAR-6 with CDC-42
was essential for viability and protein localization in early C. elegans
embryos (Aceto et al., 2006). Here we report the biochemical inter-
actions of PAR-6with its partners in C. elegans alongwith the results of
tests of the role of these interactions in vivo.
The PB1 domain is required for PAR-6 localization and function
An internal deletion in PAR-6 that prevents or dramatically reduces
its binding to PKC-3 renders the protein unable to localize cortically
and unable to compensate for absence of maternally-provided PAR-6.
This result is consistent with previous observations that PAR-6 is not
localized at the cortex in pkc-3(RNAi) embryos (Beers and Kemphues,
2006). One possible interpretation of our result is that in wild-type
embryos, direct binding to PKC-3 recruits PAR-6 to the cortex. How-
ever, previous work from our lab showed that upon reduction of the
chaperone protein CDC-37 by RNAi, PAR-6 localizes to the cortex
independently of PKC-3, while the cortical localization of PKC-3 still
requires PAR-6 (Beers and Kemphues, 2006). Thus it is unlikely that
PKC-3 directly brings PAR-6 to the cortex. Instead, we propose that
PAR-6 targets PKC-3 to the cortex but that PKC-3 binding, and perhaps
activity, is required for stable cortical association of PAR-6. One activity
of PKC-3might be to antagonize the activity of clients of the chaperone
CDC-37 that normally block PAR-6 recruitment to the cortex (Beers
and Kemphues, 2006). Reduction of PKC-3 activity at the cortexwould
also be expected to result in abnormal accumulation of PAR-2 and
perhaps PAR-1 at the anterior cortex (Hao et al., 2006) and these two
proteins would be expected to antagonize accumulation of PAR-6
(Hung and Kemphues, 1999).
We do not knowwhether this requirement for interaction between
PAR-6 and PKC-3 extends to epithelial cells during late embryonic and
larval development because our experiments to test this were incon-
clusive, possibly because blocking the interaction renders PAR-6 dom-
inant negative in this developmental context.
C. elegans PAR-6 can bind directly to PAR-3 in vitro through a novel
PDZ–PDZ interaction
As expected from analysis in other animals, we found that PAR-6
binds to PAR-3 in vitro and that this binding occurs via a PDZ/PDZ
interaction. We determined that the binding between the two PDZ
domains occurs via a novel interaction between the βC strand of
PAR-6 PDZ and theβD strand of PAR-3 PDZ1. This PDZ–PDZ interactiondiffers from that of nNOS PDZ with the PDZ domains of Syntrophin or
PSD95, in which a C-terminal extension of nNOS PDZ forms a β ﬁnger
that mimicks a canonical C-terminal ligand (Hillier et al., 1999). Our
results are consistent with another study showing that Pals1 and a
synthetic ligand, both of which are known to bind at the hydropho-
bic pocket of the PDZ domain, do not compete with Par3 binding to
Par6 (Peterson et al., 2004). Consistent with results from Drosophila
(Peterson et al., 2004), the interaction between PAR-6 and PAR-3 is
weak. This might explain why roughly equal amounts of PKC-3 co-
precipitated with PAR-6 from embryonic extracts, but only a small
amount of PAR-3 could be detected. This weak binding could explain
the discrepancies that exist among data from different groups on
whether mammalian Par3 and Par6 directly interact with each other,
and if so, which regions are sufﬁcient to mediate their interaction
(Joberty et al., 2000; Lin et al., 2000; Suzuki et al., 2001). It could also
explain why attempts to co-immunoprecipitate the proteins from
Drosophila embryo extracts by either Par6 antibodies or Par3 anti-
bodies were unsuccessful (Petronczki and Knoblich, 2001).
Direct interaction between PAR-3 and PAR-6 is not essential for PAR-6
function
In contrast to our results with blocking PAR-6 binding to PKC-3, we
found that a par-6mutation that blocks or greatly reduces the ability of
PAR-6 to bind to PAR-3 has little or no effect on function of the protein.
This result adds to accumulating evidence that despite the frequent
observation of biochemical interactions between the proteins, direct
binding between PAR-3 and PAR-6 may not play a signiﬁcant role in
their function. In Drosophila epithelial cells and photoreceptors, the
distribution pattern of Baz (Par-3) is different from that of Par-6 and
aPKC (Harris and Peifer, 2005; Nam and Choi, 2003), also suggesting
that direct binding of Par-6 and Par-3 may not be an important com-
ponent of the polarity system in some contexts. Furthermore, PDZ1
was found to be nonessential for human Par3 to rescue the conse-
quences of RNAi-induced depletion of Par-3 fromMDCK II cells (Chen
and Macara, 2005). We obtained similar results in C. elegans; a par-3
transgene lacking the PDZ1 domain, which binds to the PAR-6 PDZ
domain in vitro rescues a par-3 loss-of-function mutation as well as a
wild-type par-3 transgene (B. Li and K. Kemphues, submitted).
We cannot rule out the possibility that interaction of PAR-3 with
PAR-6 is an in vitro artifact. However, repeated reports of binding
using different assays in other systems argue against this possibility
(Joberty et al., 2000; Johansson et al., 2000; Lin et al., 2000; Peterson
et al., 2004). Alternatively, this weak interaction may make a subtle
contribution to the normal function of the system, providing a level of
redundancy that ensures faithful execution of cell polarity. Perhaps
other proteins in the PAR-6 complex link PAR-6 and PAR-3 together
even when their direct interaction is disrupted. Our observation that
PAR-6F192Y, D198P:GFP co-localizes to cortical puncta containing PAR-3
to the same extent as PAR-6::GFP and the observation by Suzuki et al.
that T7-wt Par6 and T7-Par6 (ΔCRIB/PDZ) could pull down the same
amount of Par3 from COS cells (Suzuki et al., 2001) are both consistent
with this possibility.
Ligand binding ability of PAR-6 PDZ may be not essential in C. elegans
The PDZ domain of Par6 can interact with many different partners
in different contexts in other animals. In mammalian cells and Droso-
phila the PDZ domain can bind to Crumbs/Crb3 (Kempkens et al.,
2006; Lemmers et al., 2004), Stardust/Pals1 (Hurd et al., 2003; Wang
et al., 2004) and perhaps Lgl (Betschinger et al., 2003; Plant et al.,
2003; Yamanaka et al., 2003). A properly folded PDZ domain also
plays an important role in binding of PAR-6 to CDC-42 (Garrard et al.,
2003; Joberty et al., 2000; Lin et al., 2000). Two of the ligands, Crumbs
and Stardust/Pals1 bind through the hydrophobic pocket of the Par6
PDZ domain, although in slightly different ways. Crumbs is typical of
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although its binding may be regulated by Cdc-42 (see below). Pals1
also binds PAR-6 via interaction with the PDZ binding pocket, but the
binding region is internal (Hurd et al., 2003; Wang et al., 2004).
Structural analysis demonstrated that this internal peptide inserts
into the hydrophobic binding pocket of Par6 PDZ in a novel way that
involves conformational change of Par6 PDZ imposed by the ligand
(Penkert et al., 2004). Par6 PDZ can also interact with Lgl (Betschinger
et al., 2003; Plant et al., 2003; Yamanaka et al., 2003), but the mech-
anism for this interaction is not clear.
Another interesting feature of Par6 PDZ is that it is structurally
and functionally coupled to the adjacent semi-CRIB motif. Although
CDC-42 mainly makes contacts with the semi-CRIB motif of Par6, this
interaction also requires the presence of the PDZ domain (Joberty
et al., 2000). Structural studies indicated that the PDZ domain makes
minor contact with Cdc42 and stabilizes the interaction between the
semi-CRIB motif and Cdc42 (Garrard et al., 2003). In turn, Cdc42
binding to the semi-CRIB motif can also modify the conformation of
the PDZ domain, which may increase the binding afﬁnity between
Par6 PDZ and its ligand (Peterson et al., 2004).
Taken together, these results led us to the hypothesis that the
PAR-6 PDZ domain binds in a conventional way to an unknown
ligand and that the binding might be regulated by CDC-42. To test
that hypothesis and to determine how PAR-6 behaves in the absence
of ligand binding, we mutated the binding pocket to block binding to
Pals1 but not CDC-42.
In our analysis, most mutations, including single point mutations
in PAR-6 PDZ affected the interaction of PAR-6 with CDC-42. Sur-
prisingly, PAR-6R166A P167A and PAR-6 P167G, mutations that severely
reduced ability to bind Pals1without disrupting CDC-42 binding, were
able to function as well as wild-type throughout the life of the worm.
A third mutant form of the protein, PAR-6K161A rescued the maternal
requirement for PAR-6 but was not tested for rescue of zygotic func-
tion. Although we cannot easily determine whether these mutant
PAR-6 proteins are completely blocked for binding of the more typical
C-terminal ligands, it seems unlikely that none of the mutations we
tested would disrupt binding to a conventional PDZ ligand. Thus, our
results raise the possibility that ligand binding to the PDZ domain is
not essential for PAR-6 function in C. elegans. In contrast to our results
with the C. elegans PAR-6 PDZ, the PDZ domain of mammalian Par6
may be important for its function. In MDCK cells, overexpression of
WT Par6 inhibited tight junction formation, whereas overexpression
of Par6KPLG167–170AAA or Par6P171G failed to inhibit (Joberty et al., 2000;
Peterson et al., 2004). However, it may be important to revisit this
question taking into account the possibility that the effect was due to
blocking binding to Cdc-42 (Peterson et al., 2004) or reducing binding
to Par-3 (Joberty et al., 2000) and using rescue of RNAi knockdown
rather than suppression of dominant negative effects to assay for
function.
Does the C. elegans PAR-6 PDZ domain function solely to facilitate
binding to CDC-42?
Assuming that our mutations successfully block the interactions
that we targeted, we are left with the surprising possibility that the
PDZ domain of C. elegans PAR-6 functions primarily to facilitate
binding to CDC-42. Our results indicating that direct binding of PAR-6
to PAR-3 is not essential are consistent with a number of previous
observations. More unexpected is our ﬁnding that mutations known
to block ligand binding do not detectably disrupt PAR-6 function. The
high degree of conservation of amino acids in the binding pocket
argues fairly compellingly for evolutionary pressure to maintain the
precise conﬁguration of the pocket. Although it is reasonable to
assume that conservation in the binding pocket reﬂects constraints
on ligand binding, it is possible that this conservation instead reﬂects
constraints on structure that preserve CDC-42 binding. Our ﬁndingthat 9 of 12 mutations we chose for their potential to disrupt ligand
binding also affect CDC-42 binding supports this latter possibility.
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